[(18)F]FDG PET/MRI enables early chemotherapy response prediction in pancreatic ductal adenocarcinoma

PURPOSE: In this prospective exploratory study, we evaluated the feasibility of [(18)F]fluorodeoxyglucose ([(18)F]FDG) PET/MRI-based chemotherapy response prediction in pancreatic ductal adenocarcinoma at two weeks upon therapy onset. MATERIAL AND METHODS: In a mixed cohort, seventeen patients treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Harder, Felix N., Jungmann, Friederike, Kaissis, Georgios A., Lohöfer, Fabian K., Ziegelmayer, Sebastian, Havel, Daniel, Quante, Michael, Reichert, Maximillian, Schmid, Roland M., Demir, Ihsan Ekin, Friess, Helmut, Wildgruber, Moritz, Siveke, Jens, Muckenhuber, Alexander, Steiger, Katja, Weichert, Wilko, Rauscher, Isabel, Eiber, Matthias, Makowski, Marcus R., Braren, Rickmer F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319249/
https://www.ncbi.nlm.nih.gov/pubmed/34322781
http://dx.doi.org/10.1186/s13550-021-00808-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319249/
https://www.ncbi.nlm.nih.gov/pubmed/34322781
http://dx.doi.org/10.1186/s13550-021-00808-4

Ejemplares similares